Vifor Pharma Ag Stock Market Capitalization
| GNHAYDelisted Stock | USD 38.39 0.00 0.00% |
Vifor Pharma AG fundamentals help investors to digest information that contributes to Vifor Pharma's financial success or failures. It also enables traders to predict the movement of Vifor Pink Sheet. The fundamental analysis module provides a way to measure Vifor Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vifor Pharma pink sheet.
Vifor |
Vifor Pharma AG Company Market Capitalization Analysis
Vifor Pharma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Vifor Pharma Market Capitalization | 12.45 B |
Most of Vifor Pharma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vifor Pharma AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Vifor Pharma AG is about 12.45 B. This is 3.76% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The market capitalization for all United States stocks is 34.55% higher than that of the company.
Vifor Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vifor Pharma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vifor Pharma could also be used in its relative valuation, which is a method of valuing Vifor Pharma by comparing valuation metrics of similar companies.Vifor Pharma is currently under evaluation in market capitalization category among its peers.
Vifor Fundamentals
| Return On Equity | 0.0665 | |||
| Return On Asset | 0.0458 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 10.99 B | |||
| Shares Outstanding | 324.46 M | |||
| Price To Earning | 30.39 X | |||
| Price To Book | 3.22 X | |||
| Price To Sales | 6.39 X | |||
| Revenue | 1.82 B | |||
| Gross Profit | 1.14 B | |||
| EBITDA | 519.6 M | |||
| Net Income | 144.4 M | |||
| Cash And Equivalents | 993.6 M | |||
| Cash Per Share | 3.06 X | |||
| Total Debt | 75 M | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 1.91 X | |||
| Book Value Per Share | 10.76 X | |||
| Cash Flow From Operations | 527.4 M | |||
| Earnings Per Share | 0.49 X | |||
| Number Of Employees | 2.2 K | |||
| Beta | 1.03 | |||
| Market Capitalization | 12.45 B | |||
| Total Asset | 5.1 B | |||
| Retained Earnings | 2.01 B | |||
| Working Capital | 567 M | |||
| Current Asset | 1.29 B | |||
| Current Liabilities | 726 M | |||
| Z Score | 99.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 5.1 B | |||
| Last Dividend Paid | 2.0 |
About Vifor Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vifor Pharma AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vifor Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vifor Pharma AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Vifor Pink Sheet
If you are still planning to invest in Vifor Pharma AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vifor Pharma's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |